Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.51
-0.71-22.05%
Last update: Oct 12, 7:16 PM
$2.47
-0.75-23.29%
CervoMed Inc (CRVO) Stock Price, Quote, News & History
CRVONASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CervoMed (NASDAQ:CRVO) through any online brokerage.
Other companies in CervoMed’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
CervoMed has a consensus price target of $26.56.
The stock price for CervoMed (NASDAQ: CRVO) is $2.47 last updated October 12, 2026 at 7:16 PM EDT.
There are no upcoming dividends for CervoMed.
CervoMed does not have any upcoming earnings scheduled.
There is no upcoming split for CervoMed.
CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
